Advanced search
Publication Cover
Acta Oncologica Volume 58, 2019 - Issue 3
Journal homepage
2,433
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: PROGNOSTIC MARKERS

Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

I. M. H. SønderstrupDepartment of Surgical Pathology Region Zealand, Zealand University Hospital, Slagelse, Denmark; Correspondence[email protected]
View further author information
,
M. B. JensenDanish Breast Cancer Cooperative Group, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; View further author information
,
B. EjlertsenDanish Breast Cancer Cooperative Group, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; ;Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; View further author information
,
J. O. EriksenDepartment of Surgical Pathology Region Zealand, Zealand University Hospital, Slagelse, Denmark; View further author information
,
A. M. GerdesDepartment of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; View further author information
,
T. A. KruseDepartment of Clinical Genetics, Odense University Hospital, Odense, DenmarkView further author information
,
M. J. LarsenDepartment of Clinical Genetics, Odense University Hospital, Odense, DenmarkView further author information
,
M. ThomassenDepartment of Clinical Genetics, Odense University Hospital, Odense, DenmarkView further author information
&
A. V. LaenkholmDepartment of Surgical Pathology Region Zealand, Zealand University Hospital, Slagelse, Denmark; View further author information
 show all
Pages 363-370 | Received 31 May 2018, Accepted 17 Oct 2018, Published online: 07 Jan 2019

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Min Fang, Wei Yin, Chunyan Qiu, Tao Song, Baihua Lin, Ying Wang, Hanchu Xiong & Shixiu Wu. (2024) Stromal B Lymphocytes Affecting Prognosis in Triple-Negative Breast Cancer by Opal/TSA Multiplexed Immunofluorescence. International Journal of Women's Health 16, pages 755-767.
Read now
R. A. Al wakeel, M. F. Saad, A. Abdel Azeez, F. Elkhiat & M. Shukry. (2019) Both experimental hypo- and hyper-thyroidism exacerbate the adverse effects of chronic heat stress in broilers. British Poultry Science 60:3, pages 330-339.
Read now

Articles from other publishers (19)

Virginia Valentini, Agostino Bucalo, Giulia Conti, Ludovica Celli, Virginia Porzio, Carlo Capalbo, Valentina Silvestri & Laura Ottini. (2024) Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond. Cancers 16:3, pages 579.
Crossref
Ionut Flaviu Faur, Amadeus Dobrescu, Adelina Ioana Clim, Paul Pasca, Catalin Prodan-Barbulescu, Bogdan Daniel Gherle, Cristi Tarta, Alexandru Isaic, Dan Brebu, Ciprian Duta, Bogdan Totolici & Gabriel Lazar. (2023) The Value of Tumor Infiltrating Lymphocytes (TIL) for Predicting the Response to Neoadjuvant Chemotherapy (NAC) in Breast Cancer according to the Molecular Subtypes. Biomedicines 11:11, pages 3037.
Crossref
Milena Ivanova, Anastasia Ormandjieva, Rumyana Dodova, Radka Kaneva & Velizar Shivarov. (2023) Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation . International Journal of Immunogenetics 50:5, pages 243-248.
Crossref
Siddhartha Deb, Anannya Chakrabarti & Stephen B. Fox. (2023) Prognostic and Predictive Biomarkers in Familial Breast Cancer. Cancers 15:4, pages 1346.
Crossref
Rosa Di Micco, Emanuela Esposito, Giuseppe Accardo, Andrea Sibilio, Andriana Kouloura, Mara Costa & Oreste Davide Gentilini. 2023. Hereditary Gastric and Breast Cancer Syndrome. Hereditary Gastric and Breast Cancer Syndrome 361 386 .
A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov & Z. K. Khachmamuk. (2022) Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations. Tumors of female reproductive system 18:2, pages 29-39.
Crossref
Tapsi Kumar, Evie Hobbs, Fei Yang, Jeffrey T. Chang, Alejandro Contreras, Edwin Roger Parra Cuentas, Haven Garber, Sanghoon Lee, Yiling Lu, Marion E. Scoggins, Beatriz E. Adrada, Gary J. Whitman, Banu K. Arun, Elizabeth A. Mittendorf & Jennifer K. Litton. (2022) Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation . Clinical Cancer Research 28:17, pages 3669-3676.
Crossref
Oğuzhan Okcu, Seda Duman Öztürk, Çiğdem Öztürk, Bayram Şen, Ayşe İrem Yasin & Recep Bedir. (2022) Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy. Annals of Diagnostic Pathology 58, pages 151930.
Crossref
Carlotta Cattolico, Peter Bailey & Simon T. Barry. (2022) Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC. Frontiers in Cell and Developmental Biology 10.
Crossref
Carmen Criscitiello, Elena Guerini-Rocco, Giulia Viale, Caterina Fumagalli, Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, Marco Invernizzi, Umberto Malapelle & Nicola Fusco. (2022) Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology. Anti-Cancer Agents in Medicinal Chemistry 22:4, pages 787-800.
Crossref
Nanna Jørgensen, Thomas Vauvert F. Hviid, Lise B. Nielsen, Ida M. H. Sønderstrup, Jens Ole Eriksen, Bent Ejlertsen, Anne-Marie Gerdes, Torben A. Kruse, Mads Thomassen, Maj-Britt Jensen & Anne-Vibeke Lænkholm. (2021) Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British Journal of Cancer 125:10, pages 1388-1398.
Crossref
Nanna Jørgensen, Anne-Vibeke Lænkholm, Susanne Gjørup Sækmose, Lone Bak Hansen & Thomas Vauvert F. Hviid. (2021) Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters. Clinical Immunology 232, pages 108847.
Crossref
Tracy Z Tien, Justina N L W Lee, Jeffrey C T Lim, Xiao‐Yang Chen, Aye Aye Thike, Puay Hoon Tan & Joe P S Yeong. (2021) Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence. Histopathology 79:2, pages 139-159.
Crossref
Svetlana Miklikova, Lenka Trnkova, Jana Plava, Martin Bohac, Marcela Kuniakova & Marina Cihova. (2021) The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer. Cancers 13:3, pages 575.
Crossref
Beatriz Grandal, Clémence Evrevin, Enora Laas, Isabelle Jardin, Sonia Rozette, Lucie Laot, Elise Dumas, Florence Coussy, Jean-Yves Pierga, Etienne Brain, Claire Saule, Dominique Stoppa-Lyonnet, Sophie Frank, Claire Sénéchal, Marick Lae, Diane De Croze, Guillaume Bataillon, Julien Guerin, Fabien Reyal & Anne-Sophie Hamy. (2020) Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers 12:12, pages 3681.
Crossref
Lin He, Yaling Wang, Qian Wu, Yuhua Song, Xuezhen Ma, Biyuan Zhang, Haiji Wang & Yong Huang. (2020) Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes: a meta-analysis. BMC Women's Health 20:1.
Crossref
Rachel Whitehair, Lauren C. Peres & Anne M. Mills. (2020) Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA Status. International Journal of Gynecological Pathology 39:6, pages 558-566.
Crossref
Carmen Criscitiello & Giuseppe Curigliano. (2020) Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumours. European Journal of Cancer 127, pages 236-239.
Crossref
Alexandra Caziuc, Diana Schlanger, Giorgiana Amarinei & George Calin Dindelegan. (2019) Can Tumor-Infiltrating Lymphocytes (TILs) Be a Predictive Factor for Lymph Nodes Status in Both Early Stage and Locally Advanced Breast Cancer?. Journal of Clinical Medicine 8:4, pages 545.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.